Dr. Chris Sweeney is Clinical Director of the Developmental Therapeutics Program in the Division of Hematology-Oncology at the Indiana University Medical School Cancer Center. Dr. Sweeney currently serves on the Cancer Education Committee of the American Society of Clinical Oncology and has peer reviewed funding from the PhRMA Foundation (Faculty Development Award), the National Institutes of Health and the Department of Defense. He is Assistant Professor in the Department of Medicine with appointments in Hematology- Oncology and Clinical Pharmacology. Dr Sweeney is also a Scientific and Clinical Advisor to Semafore Pharmaceuticals. He received his medical degrees from the University of Adelaide, South Australia, and completed an internship at the Royal Adelaide Hospital.